Table VII. Univariate and multivariate analyses of risk factors for overall survival in patients receiving gemcitabine plus nab-paclitaxel for pancreatic ductal adenocarcinoma.

OS: Overall survival; CI: confidence interval; R: resectable; BR: borderline resectable; UR-LA: unresectable-locally advanced; UR-M: unresectablemetastasis; CA19-9: carbohydrate antigen 19-9; NLR: neutrophil-to-lymphocyte ratio; PLR: platelet-to-lymphocyte ratio; LMR: lymphocyte-tomonocyte ratio; PNI: prognostic nutrition ratio; CONUT: controlling nutrition status; GPS: Glasgow prognostic score; HbA1c: hemoglobin A1c.